Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Cash & Equivalents (2013 - 2026)

Xencor (XNCR) posted quarterly Cash & Equivalents of $14.2 million for Q1 2026, down 64.28% year-over-year from $39.7 million in Q1 2025, and down 73.79% quarter-over-quarter from $54.1 million in Q4 2025.

Analysis

Xencor (XNCR) Cash & Equivalents (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Cash & Equivalents for 14 consecutive years, with $14.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Equivalents fell 64.28% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (down 64.28% YoY), while the FY2025 annual figure was $54.1 million, up 32.29% from the prior year.
  • Cash & Equivalents slipped to $14.2 million in Q1 2026 per XNCR's latest filing, from $54.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $78.3 million in Q1 2022 and bottomed at $14.2 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $44.7 million across 5 years, with a median of $44.4 million in 2025.
  • Annual changes were most pronounced in 2025 — Cash & Equivalents surged 44.44% — and 2026, when it plunged 64.28%.
  • Xencor's Cash & Equivalents stood at $53.9 million in 2022, then retreated by 0.28% to $53.8 million in 2023, then declined by 24.01% to $40.9 million in 2024, then jumped by 32.29% to $54.1 million in 2025, then slumped by 73.79% to $14.2 million in 2026.
  • Business Quant data shows XNCR's Cash & Equivalents at $14.2 million in Q1 2026, $54.1 million in Q4 2025, and $28.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 Xencor 2.02 Bn 1.65 Bn - 44.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.66 Mn
Mar 31, 2026 14.17 Mn
Dec 31, 2025 54.07 Mn
Sep 30, 2025 28.29 Mn
Jun 30, 2025 44.44 Mn
Mar 31, 2025 39.68 Mn
Dec 31, 2024 40.88 Mn
Sep 30, 2024 29.03 Mn
Jun 30, 2024 30.77 Mn
Mar 31, 2024 31.03 Mn
Dec 31, 2023 53.79 Mn
Sep 30, 2023 52.73 Mn
Jun 30, 2023 34.71 Mn
Mar 31, 2023 72.39 Mn
Dec 31, 2022 53.94 Mn
Sep 30, 2022 52.65 Mn
Jun 30, 2022 49.41 Mn
Mar 31, 2022 78.27 Mn
Dec 31, 2021 143.48 Mn
Sep 30, 2021 41.20 Mn